Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis

Inclusion Criteria:

• Age ≥18 years old, ≤75 years old;
• Meet the diagnostic criteria for cardiac neurosis: the patient has palpitations,precordial pain, chest tightness, shortness of breath, dyspnea, dizziness, insomniaand dreaminess, cold hands and feet, hyperhidrosis and other cardiovascular symptomsand neurological disorders;
• Meet the diagnostic criteria of Heyisheng type palpitations in Mongolian medicine;
• There is no objective diagnosis of coronary heart disease (in accordance with any ofthe following): ①The activity flat test is negative; ② Coronary angiography orcoronary CTA suggests that the lumen stenosis is ≤50%; ③ Exercise or drug loadradionuclide examination results suggest no myocardial ischemia;
• The patient did not take anti-anxiety and depression drugs or psychotropic drugswithin 2 weeks before enrollment;
• agrees to voluntarily participate in the study and signs an informed consent form .

Exclusion Criteria:

• Accompanied by organic heart disease, severe cardiopulmonary insufficiency;
• Poor hypertension control (systolic blood pressure ≥160mmHg or diastolic bloodpressure ≥100mmHg after treatment);
• Those with malignant arrhythmia;
• Those who use pacemakers;
• Patients with hyperthyroidism;
• Combined with severe liver and kidney damage (ALT, AST or TBIL> 2 times the upperlimit of the normal reference value, or Cr> 1.5 times the upper limit of the normalreference value);
• People with serious primary diseases such as hematopoietic system or mental illness;
• SAS≥70;
• SDS≥73;
• Accompanying any other serious diseases or conditions such as malignant tumors;
• Women during pregnancy and lactation;
• People with allergies or allergies to the known ingredients of the research drug;
• Participated in other clinical research in the past 3 months;
• According to the judgment of the investigator, the subject is not suitable forresearch observation.